Current Trends in Enzyme Inhibition and Docking Analysis in Drug Design-Part -II

Author(s): Athina Geronikaki

Journal Name: Current Topics in Medicinal Chemistry

Volume 20 , Issue 29 , 2020

Become EABM
Become Reviewer
Call for Editor

Angira, D.; Natarajan, N.; Dedania, S.R.; Patel, D.H.; Thiruvenkatam, V. Characterization of p. aeruginosa glucose 6- phosphate isomerase: a functional insight via in-vitro activity study. Curr. Top. Med. Chem., 2020, 20(29), 2651-2661.
Dey, R.; Nandi, S.; Samadder, A.; Saxena, A.; Saxena, A.K. Exploring the potential inhibition of candidate drug molecules for clinical investigation based on their docking or crystallographic analyses against m. tuberculosis enzyme targets. Curr. Top. Med. Chem., 2020, 20(29), 2662-2680.
Geronikaki, A.; Kartsev, V.; Eleftheriou, P.; Petrou, A.; Glamočlija, J. Ciric., A.; Soković, M. Substituted 6,7-dimethoxy-5-oxo-2,3,5,9b-tetrahydrothiazolo[2,3-a]isoin-dole-3-1,1-dioxide derivatives with antimicrobial activity and docking assisted prediction of the mechanism of their antibacterial and antifungal properties. Curr. Top. Med. Chem., 2020, 20(29), 2681-2691.
Nandi, S.; Saxena, M. Potential inhibitors of protein tyrosine phosphatase (ptp1b) enzyme: promising target for type-ii diabetes mellitus. Curr. Top. Med. Chem., 2020, 20(29), 2692-2707.
Hussain, J.; Kirubakaran, S.; Ravi, S. The endeavours in ras inhibition - the past, present, and future. Curr. Top. Med. Chem., 2020, 20(29), 2708-2722.
Saxena, A.K.; Alam, M. ATP synthase inhibitors as anti-tubercular agents: qsar studies in novel substituted quinolones. Curr. Top. Med. Chem., 2020, 20(29), 2723-2734.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [2649 - 2650]
Pages: 2
DOI: 10.2174/156802662029201103090350

Article Metrics

PDF: 22